Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors.
about
The Membrane Steps of Bacterial Cell Wall Synthesis as Antibiotic TargetsStructural insights into inhibition of lipid I production in bacterial cell wall synthesis.Purification and characterization of the bacterial MraY translocase catalyzing the first membrane step of peptidoglycan biosynthesis.The bacterial cell wall as a source of antibacterial targets.Modeling bacterial UDP-HexNAc: polyprenol-P HexNAc-1-P transferases.Fluorescence detection-based functional assay for high-throughput screening for MraY.Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis PathwayThe biosynthesis of peptidoglycan lipid-linked intermediates.Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis.Chemical modification of capuramycins to enhance antibacterial activityEffect of uridine protecting groups on the diastereoselectivity of uridine-derived aldehyde 5'-alkynylation.Structure-based gene targeting discovery of sphaerimicin, a bacterial translocase I inhibitorSynthesis of gem-difluorinated nucleoside analogues of the liposidomycins and evaluation as MraY inhibitors.Bacterial phosphoglycosyl transferases: initiators of glycan biosynthesis at the membrane interface.Function-Oriented Synthesis: How to Design Simplified Analogues of Antibacterial Nucleoside Natural Products?5'-Methylene-triazole-substituted-aminoribosyl uridines as MraY inhibitors: synthesis, biological evaluation and molecular modeling.Total Synthesis of (−)-Caprazamycin ATotal Synthesis of (−)-Caprazamycin A
P2860
Q26738402-4335A061-DEC8-4ED0-823B-5541B7D126E1Q28833309-CD62C50E-73D0-4263-A713-4FC6BC494879Q30831090-DBE2CA92-156E-4826-AB58-DE9C7FDBC087Q34568935-C7ED6686-B71A-4C68-8DBD-CFBF77FD72B6Q36103402-4282B61C-E15C-4653-90A0-BDB872BD816CQ36492019-66781A8C-47B6-490C-B458-07C6EF9DC453Q36518393-ED06B345-FF4D-4D12-A7D6-CFABA25E6397Q37032866-3E61E122-9440-4245-84F9-3B73FFF38125Q37683527-F70EFCD9-3913-42D8-815D-8B5144EBAA00Q39615555-2C1266D3-496D-4D09-A5B3-08EE011BEBACQ41334870-978E998C-B2BA-406C-8E96-72DCB9F0A910Q42080577-9FBBFCFA-9007-43D8-B4D8-D52DC207F86DQ46853876-07907E10-7BBB-46D9-8C1F-CD484A8D54F9Q47949690-4DCC3707-F032-4B08-B0E9-0641028E5C7DQ50865707-0098D3C0-EA44-4DBD-A618-CB8F9650CD1AQ53841671-1C7A8EA5-E55B-4C4F-82DB-6CE7E5C9799BQ57749491-F2403E5F-A5B7-4700-A3DD-3CC6DEFB2517Q57749495-986FF14E-C1DD-4F9E-9AD0-276496F45D38
P2860
Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Synthesis of the nucleoside mo ...... his family of MraY inhibitors.
@ast
Synthesis of the nucleoside mo ...... his family of MraY inhibitors.
@en
type
label
Synthesis of the nucleoside mo ...... his family of MraY inhibitors.
@ast
Synthesis of the nucleoside mo ...... his family of MraY inhibitors.
@en
prefLabel
Synthesis of the nucleoside mo ...... his family of MraY inhibitors.
@ast
Synthesis of the nucleoside mo ...... his family of MraY inhibitors.
@en
P2093
P1476
Synthesis of the nucleoside mo ...... his family of MraY inhibitors.
@en
P2093
Collette P
Guillot JC
P304
P356
10.1016/S0960-894X(00)00349-8
P407
P577
2000-08-01T00:00:00Z